Healthcare services, MedTech, and digital health remain core to global M&A, underpinned by structural tailwinds: ageing populations, rising healthcare costs, and digitisation. From specialist clinics to contract development and manufacturing organisations (CDMOs), and from diagnostics to preventative care, investors continue to pursue resilient, scalable assets.

Digital health and technology-enabled platforms are accelerating transformation across the sector, driving efficiency and patient-centric outcomes. Fragmented ecosystems create opportunities for buy-and-build strategies, with private equity and corporate acquirers actively consolidating providers across multiple geographies.

Clavana originates proprietary healthcare M&A opportunities worldwide, connecting investors with founder-led businesses and platforms driving change. Our research-led approach ensures early visibility into assets aligned with investment theses, from MedTech and CDMOs to specialised services and digital health platforms.